Whilst DN continues to be the principal cause of podocytopathy, there remains a major knowledge gap in the role of nephrin and anti-nephrin autoantibodies as an early diagnostic and prognostic marker to assess kidney disease progression. Here, NPHS1 is linked to liver dysplastic nodule.